CRISPR-Based Precision Molecular Diagnostics for Disease Detection and Surveillance.

Area of Science:

• Molecular Biology
• Biotechnology
• Medical Diagnostics

Background:

• The COVID-19 pandemic highlighted the need for advanced disease surveillance and rapid diagnostic tools.
• CRISPR-Cas systems have emerged as powerful tools for genetic manipulation and sequence-specific gene editing.
• The development of CRISPR-Cas technology has opened new avenues in molecular diagnostics.

Purpose of the Study:

• To review the advancements and applications of CRISPR-Cas systems in molecular diagnostics.
• To provide a comprehensive understanding of CRISPR-Cas based diagnostic methods.
• To highlight the potential of CRISPR-Cas for point-of-care diagnostics.

Main Methods:

• Review of scientific literature on CRISPR-Cas systems and molecular diagnostics.
• Analysis of CRISPR-Cas applications in enhancing sensitivity, accuracy, and portability of diagnostic tests.
• Exploration of CRISPR-Cas based methods for point-of-care applications.

Main Results:

• CRISPR-Cas technology has significantly improved the sensitivity, accuracy, and portability of molecular diagnostics.
• CRISPR-Cas systems enable rapid and specific detection of various pathogens.
• The technology shows great promise for developing effective point-of-care diagnostic solutions.

Conclusions:

• CRISPR-Cas systems represent a transformative technology for molecular diagnostics.
• These systems are crucial for future disease surveillance, containment, and therapy.
• Further development of CRISPR-Cas diagnostics will enhance global health security.